DATATRAK International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 at 03:36 pm EST
Share
DATATRAK International, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 1.52 million compared to USD 1.75 million a year ago. Net loss was USD 0.431366 million compared to USD 0.026724 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.18 compared to USD 0.01 a year ago.
For the nine months, sales was USD 4.79 million compared to USD 5.45 million a year ago. Net income was USD 0.081316 million compared to net loss of USD 0.001856 million a year ago. Basic earnings per share from continuing operations was USD 0.03. Diluted earnings per share from continuing operations was USD 0.03.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
